-
Drovix Launches In-House Multi-Asset Liquidity and Execution Stack for Sub-Millisecond Fills, Tighter Spreads
-
Australia charges man with trying to pass Ukraine military intel to Russia
-
'So bad it's good': rough animated film becomes surprise Chinese hit
-
Ex-Pakistan PM Khan taken back to jail after hospital checks: govt
-
'I'll adapt': First pregnant candidate navigates French presidential race
-
China, Indonesia hold talks on security, defence
-
Hong Kong convicts Tiananmen vigil activists of inciting subversion
-
Train to nowhere? South Korea's lonely push for peace with the North
-
The Hong Kong Tiananmen vigil activists convicted in national security trial
-
Australia's Hussey mulls role with England for Ashes series
-
Eel-powered Japan whizz-kid, 11, chases Asian Games history
-
Indian captain 'scapegoat' in Britain's Russia shadow fleet case, wife says
-
Asian markets extend rally as traders assess US Treasuries pledge
-
Rosenior seeks to match Paris FC's capital ambition as Ligue 1 returns
-
Barcelona enter new era as Flick targets La Liga hat-trick
-
Inter set for Serie A title defence as Milan get Amorim reboot
-
Pogacar favourite for Vuelta with Grand Tour treble in sight
-
'Greatest' Springboks face All Blacks in clash of juggernauts
-
Bangladesh coach Simmons wary of Australia backlash in second Test
-
William and Harry: Britain's warring royal brothers
-
Hong Kong Tiananmen activists to receive national security verdict
-
UN holds second informal poll for next leader
-
Who are the candidates vying to lead the UN?
-
In US mining hub, black lung rates soar
-
Swiatek into Cincinnati semis after Rybakina injury
-
Champions Arsenal embrace being 'hunted' as Premier League returns
-
University suspends academic behind Jason Arday plagiarism charges
-
World No.2 Rybakina retires from Cincinnati clash with Swiatek
-
Key European leaders demand Israel halt West Bank settlement project
-
'I heard you missed me': Melania Trump jokes about month out of spotlight
-
Kiwi Ears Stardust: The Art of Natural Balance
-
IRA-Eligible Gold: Rules, Approved Coins, and Best Gold Dealers (Guide Released)
-
McIlroy bounces back to share BMW Championship lead
-
Amazon Prime Video to invest $2 bn in Latin America productions
-
Cobolli fueled by candy in sweet defeat of Paul
-
Panama Canal to reduce shipping over El Nino-fueled drought
-
Jailed Pakistan ex-PM Khan moved to hospital on court order: party
-
Maradona trial on hold over possible medical evidence mix-up
-
Pogacar eyes 'missing' piece ahead of Vuelta return
-
'Green dilemma': China's solar boom hurt birds, says study
-
US, Canada 'very close' to trade deal, Ottawa says, as details emerge
-
Pegula hangs on to dispatch Anisimova, reach Cincinnati semi-finals
-
Ronaldinho returns in search of 'beautiful' 300th goal
-
US charges woman with IS-inspired plot to blow up New York State Capitol
-
US pushes allies, China to back Trump's economic war on Iran
-
What a record-breaking El Nino could mean for the world
-
Former NBA MVP Harden reportedly set to return to Cavaliers
-
Duplantis edges Karalis to win Lausanne Diamond League pole vault
-
Brook makes Pakistan pay for drop as England dominate first Test
-
Alcaraz to return for US Open title defence
Medical Care Technologies Continues Rigorous Testing of MDCE Melanoma Scan While Evaluating Expansion Opportunities (OTC Pink:MDCE)
Company Maintains Active Development of Core AI Imaging Technology Alongside Diversified Revenue Platforms and Strategic Growth Considerations
MESA, AZ / ACCESS Newswire / August 3, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today provided an update on the continued rigorous testing of its MDCE Melanoma Scan Beta platform and the Company's broader expansion outlook.

The Company remains actively engaged in structured evaluation and model training for MDCE Melanoma Scan Beta, applying multi-phase testing protocols focused on image quality, consistency, and performance across varied datasets. These efforts form part of MDCE's ongoing commitment to technical refinement of its proprietary AI vision systems.
In parallel, Medical Care Technologies continues to operate a diversified model that includes revenue-generating subsidiaries and consumer applications. The Company is also evaluating opportunities to expand through selective partnerships and potential brand acquisitions that align with its software development, AI vision, and digital platform capabilities.
"We are maintaining disciplined progress on MDCE Melanoma Scan while building commercial strength across our broader technology portfolio," said Marshall Perkins, CEO of Medical Care Technologies. "Our diversified approach allows us to generate revenue from existing platforms even as we advance core medical imaging tools and explore measured expansion opportunities."
Medical Care Technologies remains focused on balancing rigorous technical development with practical monetization and strategic growth initiatives.
About Medical Care Technologies Inc. Medical Care Technologies Inc. (OTC Pink: MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used, which provide complementary revenue-generating operations. Visit: https://medicalcaretechnologies.com
About Infinite Auctions Infinite Auctions is a wholly-owned subsidiary of Medical Care Technologies Inc. specializing in premium sports memorabilia auctions through its innovative online platform. Visit: https://infiniteauctions.com
About Real Game Used Real Game Used is a wholly-owned subsidiary of Medical Care Technologies Inc. specializing in AI-enhanced photo match authentication for sports and entertainment memorabilia. Visit: https://realgameused.com
Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information: Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750 Email: [email protected] Websites: https://medicalcaretechnologies.com | https://infiniteauctions.com | https://realgameused.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
T.Wright--AT